Combination Antiretroviral Therapy and the Risk of Myocardial Infarction

This publication has 23 references indexed in Scilit:

• Incidence of Myocardial Infarction in Randomized Clinical Trials of Protease Inhibitor-Based Antiretroviral Therapy: An Analysis of Four Different Protease Inhibitors
  AIDS Research and Human Retroviruses, 2003
• Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
  AIDS, 2003
• Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 2003
• Modelling the 3‐year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti‐HIV Drugs (DAD) study
  HIV Medicine, 2003
• Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV-1 Infection?
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Body Habitus Changes and Metabolic Alterations in Protease Inhibitor–Naive HIV-1–Infected Patients Treated With Two Nucleoside Reverse Transcriptase Inhibitors
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Changing patterns of mortality across Europe in patients infected with HIV-1
  The Lancet, 1998
• Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
  New England Journal of Medicine, 1998
• Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
  Circulation, 1994